OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2022-08-24
- Target Recruit Count
- 16
- Registration Number
- NCT04241965
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, Ormond Beach, Florida, United States
Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
- First Posted Date
- 2019-12-04
- Last Posted Date
- 2024-10-03
- Target Recruit Count
- 201
- Registration Number
- NCT04186403
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, New York, New York, United States
Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2025-05-30
- Target Recruit Count
- 591
- Registration Number
- NCT04174170
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, New York, New York, United States
Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
- Conditions
- Irritability Associated With Autism Spectrum Disorder (ASD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2023-08-14
- Target Recruit Count
- 119
- Registration Number
- NCT04174365
- Locations
- 🇺🇸
For additional information regarding sites, Princeton, New Jersey, United States
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD
- Conditions
- Post Traumatic Stress Disorder
- Interventions
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2025-06-13
- Target Recruit Count
- 450
- Registration Number
- NCT04124614
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, San Diego, California, United States
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
- First Posted Date
- 2019-10-04
- Last Posted Date
- 2024-06-28
- Target Recruit Count
- 475
- Registration Number
- NCT04115319
- Locations
- 🇺🇸
Synexus Clinical Research US, Inc., Cerritos, California, United States
🇺🇸Pacific Research Partners, Oakland, California, United States
🇺🇸Excell Research, Oceanside, California, United States
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
- First Posted Date
- 2019-10-01
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 463
- Registration Number
- NCT04109950
- Locations
- 🇺🇦
Research Site, Vinnytsia, Ukraine
A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
- Conditions
- Borderline Personality Disorder
- Interventions
- Other: Placebo
- First Posted Date
- 2019-09-24
- Last Posted Date
- 2024-07-18
- Target Recruit Count
- 332
- Registration Number
- NCT04100096
- Locations
- 🇺🇸
Pillar Clinical Research, Richardson, Texas, United States
🇺🇸CI Trials, Santa Ana, California, United States
🇺🇸Care Access Research Beverly Hills, Beverly Hills, California, United States
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2024-06-26
- Target Recruit Count
- 464
- Registration Number
- NCT04092686
- Locations
- 🇺🇸
Woodland Research Northwest, Rogers, Arkansas, United States
🇺🇸Advanced Research Center, Inc., Anaheim, California, United States
🇺🇸Clinical Innovations, Inc., Bellflower, California, United States
Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2023-01-13
- Target Recruit Count
- 13
- Registration Number
- NCT04081363
- Locations
- 🇺🇸
For additional information regarding sites, contact 844-687-8522, New York, New York, United States